M
JAZZ icon

MOTCO’s Jazz Pharmaceuticals JAZZ Stock Holding History

MOTCO’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482 Buy
+2
New +$438 ﹤0.01% 684
2014
Q4 		– Sell
-192
Closed -$31K – 626
2014
Q3 		$31K Buy
+192
New +$29.5K ﹤0.01% 327

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

MOTCO's JAZZ Position: Q2 2026 in Review

MOTCO opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2 shares worth $482. The stake represents ﹤0.01% of the portfolio and ranks #684 among its holdings. This is a return to the name: MOTCO previously reported a position in JAZZ as recently as Q3 2014.

MOTCO first reported a position in JAZZ in Q3 2014 and has held it in 2 quarters since. The position peaked at $31K in Q3 2014. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • MOTCO held 2 shares of Jazz Pharmaceuticals worth $482 as of Q2 2026.
  • Jazz Pharmaceuticals was a new MOTCO position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #684 holding.
  • MOTCO first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 2 quarters since.
  • MOTCO's Jazz Pharmaceuticals position peaked at $31K in Q3 2014.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.